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Abstract 
The mechanisms involved in 'priming' of the oxidase response of neutrophils are unknown. Two major problems are encountered in 
using circulating neutrophils; firstly, prior exposure to circulating 'priming' cytokines cannot be controlled and secondly, non-intentional 
'priming' during cell separation can occur. In this study, these problems were avoided by differentiating the promyeloid leukaemic cell 
line, HL60, towards granulocytes u ing dibutyrl cyclic AMP, to produce a 'virgin cell' model system. We have demonstrated that the 
ability of substance P to both prime the oxidase response and induce tyrosine phosphorylation increased during differentiation. The major 
tyrosine-phosphorylated protein, with molecular weight of 74 kDa, was not recognised by anti-c-rafl antibodies. Furthermore, c-rafl 
expression rapidly declined uring HL60 cell granulocytic differentiation. This data shows that although there was no simple relationship 
between c-raf quantity and priming, the data were consistent with tyrosine phosphorylation f a 74 kDa protein being important for 
oxidase ' priming'. 
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1. Introduction 
The ability of polymorphonuclear neutrophilic leuko- 
cytes (neutrophils) to protect against infecting micro- 
organisms is dependent ¢,n 'priming' and activation of a 
non-mitochondrial oxidase [1]. Priming of neutrophils re- 
suits in a more exaggerated oxidase response to subsequent 
stimulation [2]. A number of priming agents have been 
identified, including the cytokines TNF-a, GM-CSF, and 
the neuropeptide, substance P [3-6]. As well as these 
agents, sub-stimulatory concentrations of agonists, such as 
f-met-leu-phe, also cause 'priming' [2]. 
Although many of the intracellular signalling events 
which trigger oxidase activation are becoming established, 
the intracellular events which signal priming still remain 
unclear. Two major problems exist with many studies on 
circulating neutrophils; (1) prior exposure of the cells to 
primers in the general circulation is uncontrolled and (2) 
method of isolation of neutrophils from blood may pro- 
duce 'priming' conditions. In this study, these problems 
were avoided by using the promyeloid leukemic ell line, 
HL-60. Treatment of this cell line with dibutyryl cyclic 
AMP induces differentiation towards granulocytes [7], pro- 
ducing cells which posse~;s many of the features of neu- 
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trophils including expression of receptors for chemoattrac- 
tants, chemotaxis, and the ability to produce superoxide in 
response to the formylated peptide f-met-leu-phe [8-10]. 
These differentiated cells provide a system in which expo- 
sure to 'priming' cytokines is controlled and no separation 
steps are required. 
The aim of this work was therefore to correlate, during 
differentiation, the ability of these 'virgin' cells to be 
'primed' with the appearance of signalling pathways. This 
approach may identify signals and proteins which are 
important in priming in mature neutrophils. We report here 
that, during the differentiation of HL60 pro-myeloid cells, 
the appearance of 'priming' by substance P was correlated 
with its ability to induce tyrosine phosphorylation. 
2. Materials and methods 
2.1. Materials 
HL60 cell line (ECCACC no: 88112501) was supplied 
from the European Collection of Animal Cell Cultures, 
PHLS, Porton, Salisbury, Wilts, UK. Reagents: sodium 
orthovanadate, formyl-methionyl-leucyl-phenylalanine, d 
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its FITC-conjugate, the stable analogue of substance P, 
[Nlell]substance P, (Arg-Pro-Lys-Gln-Gln-Phe-Phe-Gly- 
Leu-NIe-NH 2) synthetic 99% purity were purchased from 
Sigma Chemicals (Poole, Dorset, UK). The mouse mono- 
clonal anti-phosphotyrosine antibody (clone PT66) was 
purchased from Sigma Chemicals (Poole, Dorset, UK) and 
Amersham International (Amersham, UK) respectively. 
Peroxidase-conjugated sheep anti-mouse and goat anti-rab- 
bit antibodies, nitrocellu],ose immunoblotting membranes 
(Hybond C + ) and ECL Western blotting detection system 
were obtained from Amersham International (Amersham, 
UK) and genistein and herbimycin A from Calbiochem 
(Cambridge, UK). Rabbit anti-human rafl kinase (rafl-III) 
polyclonal antibody, was obtained from TCS Biologicals, 
Buckingham, UK and mouse anti-human C-Rafl (III) ki- 
nase antibody from Oncogene Science (Uniondale, NY, 
USA). Human recombin~mt TNF-c~ was a kind gift from 
Dr. N. Matthews, UWCM. All other chemicals from 
Aldrich, Poole, UK. 
2.2. Cell culture conditions and induction of differentiation 
nm and at 380 nm and emission at 505 nm, recorded using 
a Spex Fluorolog II (Glen Spectra, Stanmore, UK) as 
previously described [12]. 
2.5. Measurement of NADPH-oxidase expression and 
priming response 
NADPH-oxidase activity was determined by the super- 
oxide dismutase inhibitable reduction of cytochrome-c re- 
duction as described by Babior et al. [13]. The amount of 
superoxide produced was calculated using the molar ex- 
tinction coefficient of 2.11 • 10 -4 M -1 cm-!  [14]. Prim- 
ing of the oxidase response was quantified by measure- 
ment of the response to f-met-leu-phe (10 nM) before and 
after treatment with the priming agent substance P (100 
nM). 
2.6. Detection of neutrophil phosphotyrosyl proteins 
Tyrosine phosphorylation was detected by immuno- 
blotting as described by Brindle et al. [15]. After incuba- 
HL60 cells were grown as a continuous suspension 
culture in RPMI 1640 medium supplemented with 10 mM 
Hepes, 2 mM L-glutamine, 10% heat-inactivated fetal calf 
serum, and streptomycin (50 /xg/ml) and penicillin (50 
i.u./ml) in a humidified 95% air and 5% CO 2 incubator. 
Granulocytic differentiation was induced in HL60 cells by 
treatment with 0.5 mM dCAMP. To evaluate differentia- 
tion, increased production of superoxide (O~-) was deter- 
mined in individual cells by monitoring intracellular NBT 
reduction into dark-blue formazan deposits [7]. All cultures 
were initiated at a concentration f 0.5-1.0 X 106 cells/ml. 
Doubling times were 24-36 h, the cell cultures were 
divided every 2-3 days to maintain a density of 0.5-1.0 X 
106 cells/ml. After granttlocytic differentiation, cells were 
suspended in Hepes-buffered Krebs medium containing 
NaCI (120 mM), KC1 (14.8 mM), KH2PO 4 (1.2 mM), 
MgSO 4 (1.2 mM), CaCI 2 (1.3 mM), Hepes (25 mM), and 
bovine serum albumin, fi'action V, (0.1% w/v),  adjusted 
to pH 7.4. 
2.3. Measurement of chemotactic peptide receptor expres- 
sion 
HL60 cell differentiation was assessed by measuring 
chemotactic peptide receptor expression by incubating 1.0 
• 106 cells with fluorescein-labelled formylated peptide (1 
/zM) for 30 min at 37 ° C. The cells are then fixed in 4% 
paraformaldehyde and stored at 4 ° C prior to FACS Analy- 
sis [11]. 
2.4. Measurement of cytosolic-free Ca e ÷ concentration 
Neutrophil cytosolic-fi:ee Ca 2+ was determined using 
fura-2 and dual wavelength excitation fluorimetry at 340 
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Fig. 1. Differentiation f HL60 cells and functional expression f formy- 
lated peptide receptors. (a) Shows the differentiation f HL60 cells after 
treatment with di-butyryl cyclic AMP (500 /xM). Cells are stained using 
Diff-Quick nuclear staining, days of granulocytic differentiation indi- 
cated. (b) Increase in formylated peptide receptor expression with time 
after btcAMP addition using fluorescein-labelled FMLP and FACS analy- 
sis. (c) Correlation offormylated peptide xpression (circle) with cytoso- 
lic free Ca 2+ responses to f-met-leu-phe (1 /zM) (square) indifferentiat- 
ing HL60 cells. (d) Cytosolic-free Ca2+ responses to f-met-leu-phe (1 
p.M) in differentiating HL60 cells at days indicated. 
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tion under the appropriate conditions, the reaction was 
terminated by the addition of Laemmli buffer (100 /zl) 
containing dithiothreitol (100 mM), sodium orthovanadate 
(10 mM), sodium fluoride (10 mM), sodium pyrophos- 
phate (30 mM), EDTA (10 mM) and aprotinin (1 /zg/ml) 
(pH 6.7), and boiling for 10 min [16]. The samples were 
sonicated for 10 s and centrifuged (10000 ×g,  8 min) 
before running samples containing equal protein load on 
8-10% PAGE gel. After electroblotting onto nitrocellulose 
(0.45 /zm pore size), and blocking with skim-powdered 
milk (10% w/v), the filters were incubated with blocking 
buffer (3%) containing anti-phosphotyrosine monoclonal 
antibody (0.5 /zg/ml) for 1 h at 25 ° C and washed 3 times 
for 5 rain. Bound antibodies were detected by incubating 
filters for 45 min in blocking buffer (3%) containing sheep 
anti-mouse IgG peroxidase-linked antibody (0.25 /zg/ml) 
at 25 ° C. The filters were then washed extensively before 
detection of peroxidase-positive bands using ECL Western 
blotting detection system (Amersham International, Amer- 
sham, UK). Blots were quantified by densitometric s an- 
ning. 
2.7. Detection of c-Rafl expression 
C-Rafl expression was detected after Western blotting 
using a similar procedure to that for phosphotyrosine, with 
the primary and secondary antibodies being a polyclonal 
anti-human rafl kinase antibody and a goat anti-rabbit 
antibody. 
3. Results 
3.1. Expression of functional formylated peptide receptors 
during differentiation ofHL60 cells 
The addition of dcAMP (500 /xM) to HL60 cells 
produced an increase in formylated peptide receptor ex- 
pression, the saturable receptor-mediated internalisation f
fluorescein labelled f-Met-Leu-Phe increased 22.6-fold af- 
ter 2 days (Fig. lb,c). These receptors were functionally 
linked to Ca: ÷ signalling, the cytosolic-free Ca: ÷ transient 
triggered by f-met-leu-phe (1 /zM) increasing to a maxi- 
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Fig. 2. Superoxide ion production and 'priming' response in maturing HL60 cells. Graphs show typical responses to fmlp, 10 nM (control) (dotted line) 
and the effect of preincubation of cells with substance P (100 nM, 1 rain) prior to FMLP addition (unbroken line) during their differentiation to mature 
granulocytes. The inset on 'day 0' shows the effect of substance P, 100 nM alone (SP) on superoxide production for the days 0-3. 
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Fig. 3. Tyrosine phosphorylation during differentiation. (a) Immunoblot of total cellular protein from maturing HL60 cells. Lanes 0, 1, 2, 3 show responses 
to 100 nM Substance P (1 min) for undifferentiated HL60 cells, 0, and 1, 2, 3 days of granulocytic differentiation. Lane C is an incubation control of day 3 
differentiated cells to show basal levels of tyrosine phosphorylation. (b) The relationship between tyrosine phosphorylation f a 74 kDa protein pp74 
(square) [22,23], a 55 kDa protein (pp 55) (triangle) and priming response (circle) during granulocytic differentiation, expressed as a percentage of the 
maximum response for comparison. The error bars show mean + S.E.M. (n = 6 priming and n = 3 tyrosine phosphorylation experiments). 
mum by day 3 (Fig. lc,d). The morphological changes of 
HL60 cells during this period were characteristic of gran- 
ulocytic differentiation but did not progress beyond the 
metamyelocyte stage (Fig. la). 
3.2. Development of NADPH-oxidase activity and priming 
The elevation in cytosolic-free Ca 2+ in response to 
f-met-leu-phe (1 /zM) triggered an increase in O~ produc- 
tion as determined by either NBT reduction or cy- 
tochrome-c reduction, reaching a maximum by day 3 (Fig. 
2). The ability of the neuropeptide primer, substance P
(100 nM), to enhance the sub-maximal superoxide produc- 
tion by f-Met-Leu-Phe, without activating the oxidase 
itself, also followed expression of the formylated peptide 
receptor and the oxidase activation signalling system (Fig. 
2). Priming was also provoked by GM-CSF and TNF-a at 
concentrations ranging from 1-100 ng/ml and 1-1000 
kDa 
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Fig. 4. Expression of c-raf is not correlated with priming. (a) Immunoblot of total cellular protein from maturing HL60 cells probed with anti-human rafl 
kinase antibody. Lanes 0, 1, 2 3, show c-rafl expression in undifferentiated, 0, and 1, 2, 3 days of granulocytic differentiation. (b) The relationship 
between c-rafl expression (square), p56 raf-like protein (triangle) and the priming response (circle) during granulocytic differentiation, expressed as a 
percentage of the maximum expression/response for comparison. The error bars show mean _+ S.E.M. (n = 6 priming and n = 3 for anti-c-rafl probing 
experiments). 
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u/ml respectively (data not shown). The magnitude of 
priming was comparable to that observed in mature neu- 
trophils [3-6]. Priming enhancement i creased with differ- 
entiation reaching a peak of 1.5- to 2.0-fold on day 3 (Fig. 
2.). 
3.3. Protein tyrosine phosphorylation during differentia- 
tion of HL60 cells 
Immunoblotting of total HL60 cell extracts with anti- 
phosphotyrosine antibodies revealed that substance P (100 
nM, 1 min) induced protein tyrosine phosphorylation i  
differentiating HL60 cells. A number of phospho-proteins 
were identified, with the most prominent proteins having 
molecular weights of 38, 55 and 74 kDa. As differentiation 
of HL60 cells proceeded, the extent of tyrosine phospho- 
rylation of these proteins increased (Fig. 3a). Tyrosine 
phosphorylation f this 74 kDa phosphoprotein (pp74) on 
stimulation with the primer was seen to be detectable as 
early as day 1 after initiation of differentiation, reaching 
maximum levels by day 3. The magnitude of tyrosine 
phosphorylation f this pp74, but not the 55 kDa phospho- 
protein (pp55) correlated with priming (Fig. 3b). 
3.4. Expression of c-rafl and priming 
A tyrosine-phosphorylated protein found in certain 
myeloid cells in response to certain growth factors, includ- 
ing GM-CSF and IL-2, that is central to the MAPkinase 
signalling pathway, has been identified as c-rafl kinase 
[17]. However, the suggestion that pp74 in HL-60 cells 
was c-rafl kinase was weakened because although c-rafl- 
74 was detectable in undifferentiated HL60 cells, its ex- 
pression was reduced on differentiation with dbcAMP (500 
/xM Fig. 4a,b). Interestingly, the anti-c-rafl antibody also 
recognised a protein of approximately 56 kDa (Fig. 4a). 
The expression of this protein increased with differentia- 
tion, reaching a maximum of expression by day 3. Further- 
more, in differentiated HL60 cells, immunoprecipitation 
with a polyclonal anti-c-rafl antibody revealed only the 
presence of a 56 kDa protein, with no detectable 74 kDa 
c-rafl. Thus, the expression of c-rafl did not correlate with 
either tyrosine phosphorylation activity or 'priming' and 
activation. 
4. Discussion 
In this study we have demonstrated that during granulo- 
cytic differentiation of HL60 cells, the ability of the oxi- 
dase response to be primed by substance P was associated 
with an increase in its ability to induce tyrosine phospho- 
rylation. The expression of the major tyrosine phospho- 
rylated protein, with molecular weight of 74 kDa protein, 
did not correlate with rafl kinase, since rafl expression 
rapidly declined uring HL60 cell granulocytic differentia- 
tion. These data show that there was no simple relationship 
between the amount of c-rafl and priming, but was consis- 
tent with tyrosine phosphorylation of a 74 kDa protein 
being a mediater of oxidase 'priming'. 
During differentiation of HL-60 cells, a number of 
important signalling proteins were expressed. As the ex- 
pression of formylated peptide receptors increased, the 
Ca 2÷ signalling and oxidase activation induced by f-met- 
leu-phe also increased. This suggested that the components 
of the signalling pathway between occupancy of the 
formylated peptide receptor, aised Ca 2+ and oxidase acti- 
vation were in place before expression of the receptors. At 
the same times, the ability of substance P to induce 
'priming' of the oxidase response and to induce tyrosine 
phosphorylation i creased. In mature circulating neu- 
trophils, tyrosine phosphorylation has been reported to 
occur with a number of 'priming' agents [18-21], includ- 
ing substance P [22]. A number of proteins with similar 
molecular weights have been reported to be tyrosine phos- 
phorylation targets, including one of 74 kDa [18-23]. We 
have shown that tyrosine phosphorylation f the 74 kDa 
protein in mature neutrophils has time- and dose- response 
characteristics onsistent with a key intermediate in the 
priming response [23]. This has led to the suggestion that 
this protein may have significance in mediating 'priming'. 
Furthermore we have reported previously that direct ma- 
nipulation of the tyrosine phosphorylation status of this 
pp74 protein using the protein tyrosine phosphatase in- 
hibitor, orthovanandate, caused priming and the tyrosine 
kinase inhibitor, genistein, inhibited priming in mature 
neutrophils [24,32]. The observation, reported here, that 
tyrosine phosphorylation also accompanies 'priming' dur- 
ing differentiation of HL-60 cells strengthens this proposal. 
One putative signalling molecule involved in neutrophil 
activation, and possibly 'priming' is MAPkinase [25,26]. 
The possibility existed that proteins on the same signalling 
pathway in other cells, including the proto-oncogene c-rafl 
serine kinase (74 kDa mol.wt.), may also be involved 
[27,28]. Tyrosine phosphorylation of c-raf has been re- 
ported in myeloid cells in response to the growth factors 
GM-CSF and IL-2 [17]. However, we show here that 
although c-raf is expressed in growing HL-60 cells, differ- 
entiation results in a rapid loss of expression. The 75 kDa 
phosphoprotein whose expression has recently been re- 
ported to reduce during differentiation f HL60 cells [29,30] 
may also be c-rafl. This reduction of c-rafl during granu- 
locyte maturation may provide an explanation for the 
failure to immunoprecipitate c-raf or detect c-raf in mature 
neutrophils [31,32]. A role for c-raf in 'priming' in either 
mature neutrophils or differentiated HL-60 cells thus seems 
unlikely. 
The mechanism by which the onset of 'priming' in 
differentiating HL60 cells is linked to tyrosine phospho- 
rylation is not established. However, at least two possibili- 
ties exist; (1) expression of the targets for tyrosine phos- 
phorylation increased uring HL60 differentiation, or (2) 
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expression of tyrosine kinase(s) which phosphorylate these 
targets increase during HL60 differentiation. Since the 
inhibition of tyrosine phosphatase activity by orthovana- 
date induced tyrosine phosphorylation f proteins of simi- 
lar size in undifferentiated HL-60 cells, the increase in 
expression of target proteins may not account for the 
increased tyrosine phosphorylation by substance P during 
differentiation. The possibility thus exists that it was ex- 
pression of tyrosine kinases which increased uring differ- 
entiation. Several tyrosine, kinases have been identified in 
mature neutrophils and differentiating HL60 cells, includ- 
ing p55 fgr, p59 hck, p56 l: ,  and p59 fyn [33,34]. Although, 
the anti-c-rafl antibody u'sed was raised against a peptide, 
it cross-reacted with another protein of 56 kDa, whose 
expression increased uring differentiation. FASTA se- 
quence homology tests between the peptide and various 
tyrosine kinases revealed a 40% identity in 15 amino acid 
overlap with the proto-oncogene tyrosine kinase p55 fgr, 
suggesting a weak sequ,znce homology may exist and 
suggesting the possibility of cross-reaction with the anti- 
body. The possibility thus exists that expression of the 
c-raf-like protein which correlated with 'priming' was 
p55 fgr. Therefore, it is possible that p55 fgr may play a role 
in 'priming' by tyrosine phosphorylating the 74 kDa pro- 
tein. 
The work presented here has demonstrated the useful- 
ness of the differentiating HL-60 'virgin' cell model sys- 
tem to study priming in vitro. The possibility exists that, in 
the future, this system may permit he elimination of key 
signalling proteins using antisense techniques. Here the 
system has demonstrated the importance of tyrosine phos- 
phorylation, and shown that the amount of c-raf does not 
correlate with 'priming'. It will now be important o 
identify the tyrosine phosphorylated signalling proteins in 
this system and in mature neutrophils, and the identity of 
the 56 kDa 'c-raf-like' protein. 
This work was supported by the Arthritis and Rheuma- 
tism Council (UK). 
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